LeonaBio (LONA) EV/EBIT: History & Chart

LeonaBio, Inc.(LONA)

Biotechnology · Bothell, WA

$5.75+0.17 (+3.05%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

About LeonaBio, Inc.

LeonaBio, Inc. operates as a biopharmaceutical firm engaged in clinical-stage development. Its core mission revolves around crafting small molecule therapies aimed at revitalizing neurological function and arresting the advancement of neurodegenerative conditions. The company's active development portfolio encompasses ATH-1105, an experimental therapy for amyotrophic lateral sclerosis (ALS) that is currently undergoing Phase 1 clinical assessment. Similarly, ATH-1020 is also in Phase 1 trials, targeting various neurodegenerative disorders. Furthermore, LeonaBio has an array of earlier-stage compounds in preclinical research. The company, which was originally established as Athira Pharma, Inc., rebranded itself as LeonaBio, Inc. in January 2026. Founded in 2011, its corporate headquarters are situated in Bothell, Washington.

Bothell, WA

19 employees

leonabio.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Mark J. Litton

View full financials

NAME	MARKET CAP	EV/EBIT RATIO	TTM	3Y	5Y
LeonaBio, Inc. (LONA)	$22.68M	N/A	N/A	N/A	N/A
Rein Therapeutics Inc. (RNTX)vs ›	$23.06M	N/A	N/A	N/A	N/A
Modular Medical, Inc. (MODD)vs ›	$22.25M	N/A	N/A	N/A	N/A
Aytu BioPharma, Inc. (AYTU)vs ›	$22.00M	N/A	21.00x	21.00x	21.00x
TherapeuticsMD, Inc. (TXMD)vs ›	$23.38M	N/A	0.54x	0.52x	0.52x
Kyntra Bio, Inc. (KYNB)vs ›	$24.13M	N/A	104.01x	104.01x	104.01x
Atossa Therapeutics, Inc. (ATOS)vs ›	$24.44M	N/A	N/A	N/A	N/A
InspireMD, Inc. (NSPR)vs ›	$24.60M	N/A	N/A	N/A	N/A
NextCure, Inc. (NXTC)vs ›	$20.53M	N/A	N/A	N/A	N/A
ABVC BioPharma, Inc. (ABVC)vs ›	$25.22M	N/A	11456.84x	11456.84x	11456.84x

NAME

MARKET CAP

EV/EBIT RATIO

TTM

LeonaBio, Inc. (LONA)

$22.68M

N/A

Rein Therapeutics Inc. (RNTX)vs ›

$23.06M

N/A

Modular Medical, Inc. (MODD)vs ›

$22.25M